sST2 as a value-added biomarker in heart failure

Soluble suppression of tumorigenicity-2 (sST2) is a biomarker widely investigated during the last few years. Its role has become clear in pathological conditions such as fibrosis and inflammation. From translational research to laboratory medicine, considerable efforts have been made to elucidate th...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinica chimica acta 2020-02, Vol.501, p.120-130
Hauptverfasser:	Lotierzo, Manuela, Dupuy, Anne Marie, Kalmanovich, Eran, Roubille, François, Cristol, Jean Paul
Format:	Artikel
Sprache:	eng
Schlagworte:	Comorbidities Heart failure with preserved ejection fraction Life Sciences Multimarker approach Personalized medicine sST2
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!